Therapeutic Recombinant Proteins : Next Generation

Not only recombinant proteins are now considered as excellent therapeutic approaches, but several blockbusters on the market belong to this class of molecules. Of the ten best-selling drugs in 2012, six of them were monoclonal antibody drugs, each with annual sales value exceeding US billion. Nevertheless, the field in terms of innovation is still very open and suggests business opportunities that are currently in development for some of them, or even, entering the market for the others.

On the 11th of November, the speakers of the “Therapeutic Recombinant Proteins - Next Generation” event will cover the wide range of business and innovation opportunities.

More details

Find an actor

4à6 de BioAlps - Ferring29.05.2018

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Kinntek chooses Pryv

Kinntek, announces that it has chosen Pryv to extend its breakthrough hand rehabilitation interactive platform with...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn